Oncogenic transformation by human papillomavirus type 16 deoxyribonucleic acid in the presence of progesterone or progestins from oral contraceptives.

scientific article published in April 1990

Oncogenic transformation by human papillomavirus type 16 deoxyribonucleic acid in the presence of progesterone or progestins from oral contraceptives. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/0002-9378(90)91323-5
P698PubMed publication ID2158235

P2093author name stringPater A
Pater MM
Bayatpour M
P433issue4
P407language of work or nameEnglishQ1860
P304page(s)1099-1103
P577publication date1990-04-01
P1433published inAmerican Journal of Obstetrics and GynecologyQ4744256
P1476titleOncogenic transformation by human papillomavirus type 16 deoxyribonucleic acid in the presence of progesterone or progestins from oral contraceptives.
P478volume162

Reverse relations

cites work (P2860)
Q404386621 Epidemiology of cervical intraepithelial neoplasia: the role of human papillomavirus
Q50700490A retrospective study on cervical intraepithelial lesions of low-grade and undetermined significance: evolution, associated factors and cytohistological correlation.
Q40853429Altered growth and viral gene expression in human papillomavirus type 16-containing cancer cell lines treated with progesterone
Q51029221Contraceptive use and reproductive history in women with cervical human papillomavirus infection.
Q37267830Depot-medroxyprogesterone acetate and combined oral contraceptive use and cervical neoplasia among women with oncogenic human papillomavirus infection
Q36687378Efficacy trial of topically administered interferon gamma-1? gel in comparison to laser treatment in cervical intraepithelial neoplasia
Q67699937Expression of cytokine receptors and markers of differentiation in human papillomavirus-infected cervical tissues
Q35614578HPV prevalence and concordance in the cervix and oral cavity of pregnant women
Q35831422Human papillomavirus 16 DNA immortalizes two types of normal human epithelial cells of the uterine cervix
Q77747953Human papillomavirus 16 in breast cancer of women treated for high grade cervical intraepithelial neoplasia (CIN III)
Q41349357Human papillomavirus infection in women. Special aspects of infectious diseases in women
Q41438690Human papillomaviruses and cervical cancer
Q37255166Human papillomaviruses and cervical neoplasia. II. Interaction of HPV with other factors.
Q42462920Immunohistochemical analysis of estrogen receptors, progesterone receptors, Ki-67 antigen, and human papillomavirus DNA in normal and neoplastic epithelium of the uterine cervix
Q35562045Influence of ovarian hormones on urogenital infection
Q45761353Is breast cancer caused by late exposure to a common virus?
Q36652482Multiple human papillomavirus type 16 glucocorticoid response elements functional for transformation, transient expression, and DNA-protein interactions
Q44993791Mutations in the ras protooncogenes are rare events in renal cell cancer
Q35533508Noncontraceptive benefits of modern low-dose oral contraceptives
Q67505364Oral contraceptives and human papillomavirus infection in cervical intraepithelial neoplasia
Q33934353Pathogenesis of genital HPV infection.
Q60654488Prevalence and persistence of human papillomavirus in postmenopausal age women
Q72095656Quantification of HPV‐16 E6‐E7 transcription in cervical intraepithelial neoplasia by reverse transcriptase polymerase chain reaction
Q35040082Relationship between steroid hormone contraceptives and HPV, cervical intraepithelial neoplasia and cervical carcinoma
Q40479366Review human papillomaviruses (HPV) in gynaecological cytology: from molecular biology to clinical testing
Q44814193Risk factors for cervical cancer in Colombia and Spain
Q34448400Role of nuclear progesterone receptor isoforms in uterine pathophysiology
Q33934843The detection of HPV DNA, the size of tampon specimens and the menstrual cycle.
Q40989058The epidemiology of cervical carcinogenesis
Q41301893The genetic program of genital human papillomaviruses in infection and cancer
Q41653500The interaction between HPV infection and estrogen metabolism in cervical carcinogenesis.
Q53402217The role of human papillomavirus in cervical adenocarcinoma carcinogenesis.
Q57561057Time since last use of oral contraceptives and risk of invasive cervical cancer

Search more.